MCID: AND014
MIFTS: 46

Androgenic Alopecia

Categories: Skin diseases

Aliases & Classifications for Androgenic Alopecia

MalaCards integrated aliases for Androgenic Alopecia:

Name: Androgenic Alopecia 12 15 32
Androgenetic Alopecia 12 71
Alopecia Androgenetica, Male Pattern Baldness 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0050801
ICD10 32 L64 L64.9
UMLS 71 C0162311

Summaries for Androgenic Alopecia

Disease Ontology : 12 An alopecia that is characterized by M-shaped hair line recession and thinning of hair at the crown of the head in males.

MalaCards based summary : Androgenic Alopecia, also known as androgenetic alopecia, is related to alopecia, androgenetic, 1 and galactorrhea. An important gene associated with Androgenic Alopecia is SHBG (Sex Hormone Binding Globulin), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Gastric cancer. The drugs Ethanol and Acetylcysteine have been mentioned in the context of this disorder. Affiliated tissues include skin, prostate and ovary, and related phenotypes are Decreased viability and Decreased viability

Wikipedia : 74 Pattern hair loss is hair loss that primarily affects the top and front of the scalp. In male-pattern... more...

Related Diseases for Androgenic Alopecia

Diseases related to Androgenic Alopecia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 239)
# Related Disease Score Top Affiliating Genes
1 alopecia, androgenetic, 1 32.5 TGFB2 SRD5A2 SRD5A1 SHBG CYP19A1 AR
2 galactorrhea 30.6 PRL IGF1
3 prostatic hyperplasia, benign 30.5 SRD5A2 SRD5A1 SHBG KLK3 AR
4 prostate disease 30.5 SRD5A2 SRD5A1 KLK3 CYP19A1 AR
5 neurofibromatosis, type ii 30.4 SRD5A1 SHBG CTNNB1
6 psychosexual disorder 30.4 SHBG PRL
7 gynecomastia 30.3 SRD5A2 SRD5A1 SHBG PRL KLK3 CYP19A1
8 prostatic hypertrophy 30.3 SRD5A2 SRD5A1 SHBG KLK3 CYP19A1 AR
9 insulin-like growth factor i 30.2 SHBG PRL INS IGF1
10 impotence 30.0 SRD5A1 SHBG PRL KLK3 INS AR
11 lipoid congenital adrenal hyperplasia 29.9 SRD5A1 SHBG PRL INS CYP19A1
12 hyperprolactinemia 29.9 SHBG PRL INS IGF1
13 telogen effluvium 29.9 SRD5A2 LPP HR FGF5 EDA2R
14 hypogonadism 29.8 SHBG PRL INS IGF1 CYP19A1 AR
15 sexual disorder 29.7 SHBG PRL KLK3 INS IGF1 AR
16 hyperandrogenism 29.7 SRD5A1 SHBG PRL INS IGF1 CYP19A1
17 polycystic ovary syndrome 29.7 SRD5A1 SHBG PRL INS IGF1 CYP19A1
18 alopecia 29.6 SRD5A2 SRD5A1 SHBG PRL KRT86 KRT15
19 hair disease 29.5 SRD5A2 SHBG LPP KRT86 KRT15 INS
20 ovarian disease 29.4 SHBG PRL INS IGF1 CYP19A1 CTNNB1
21 body mass index quantitative trait locus 11 29.0 SHBG PRL INS IGF1 CYP19A1 CTNNB1
22 prostate cancer 27.6 TGFB2 SRD5A2 SRD5A1 SHBG KLK3 INS
23 marie unna congenital hypotrichosis 11.5
24 hypotrichosis 1 11.4
25 hypotrichosis simplex 11.4
26 frontal fibrosing alopecia 10.5
27 prostate adenoid cystic carcinoma 10.5 KLK3 AR
28 prostate leiomyoma 10.5 KLK3 AR
29 inhibited female orgasm 10.5 SHBG PRL
30 prostate calculus 10.5 KLK3 AR
31 rapidly involuting congenital hemangioma 10.5
32 postmenopausal atrophic vaginitis 10.5 SHBG CYP19A1
33 prostatic acinar adenocarcinoma 10.5 KLK3 AR
34 hypoactive sexual desire disorder 10.4 SHBG PRL CYP19A1
35 complete androgen insensitivity syndrome 10.4 SHBG CYP19A1 AR
36 estrogen excess 10.4 SHBG PRL CYP19A1
37 hermaphroditism 10.4 SRD5A2 SHBG AR
38 liver adenomatosis 10.4 CTNNB1 AR
39 pseudovaginal perineoscrotal hypospadias 10.4 SRD5A2 SRD5A1 AR
40 hypospadias 10.4 SRD5A2 SRD5A1 AR
41 pelvic varices 10.4 SHBG PRL KLK3
42 transsexualism 10.4 SRD5A2 CYP19A1 AR
43 varicocele 10.4 SHBG PRL AR
44 oligospermia 10.3 SRD5A2 PRL AR
45 prostatitis 10.3 PRL KLK3 AR
46 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.3
47 diffuse alopecia areata 10.3
48 urolithiasis 10.3
49 infant gynecomastia 10.3
50 contact dermatitis 10.3

Graphical network of the top 20 diseases related to Androgenic Alopecia:



Diseases related to Androgenic Alopecia

Symptoms & Phenotypes for Androgenic Alopecia

GenomeRNAi Phenotypes related to Androgenic Alopecia according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00249-S 9.4 FGF5 FGF7 SRD5A1 SRD5A2
2 Decreased viability GR00381-A-1 9.4 KRT86
3 Decreased viability GR00386-A-1 9.4 FGF7 LPP SRD5A1 SRD5A2 TGFB2
4 Decreased viability GR00402-S-2 9.4 FGF5 KRT86

MGI Mouse Phenotypes related to Androgenic Alopecia:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 10.02 AR CTNNB1 CYP19A1 HR IGF1 INS
2 integument MP:0010771 9.91 AR CTNNB1 CYP19A1 FGF5 FGF7 HR
3 nervous system MP:0003631 9.9 AR CTNNB1 CYP19A1 DKK1 EFNA3 FGF7
4 renal/urinary system MP:0005367 9.61 AR CTNNB1 CYP19A1 DKK1 FGF7 HR
5 reproductive system MP:0005389 9.4 AR CTNNB1 CYP19A1 FGF7 HR IGF1

Drugs & Therapeutics for Androgenic Alopecia

Drugs for Androgenic Alopecia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 68)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 4 64-17-5 702
2
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
3
Histamine Approved, Investigational Phase 4 51-45-6 774
4
Cetirizine Approved Phase 4 83881-51-0 2678
5
Cysteine Approved, Nutraceutical Phase 4 52-90-4 5862
6 Anti-Infective Agents Phase 4
7 Anti-Infective Agents, Local Phase 4
8 Fenugreek Phase 4
9 Fenugreek seed meal Phase 4
10 N-monoacetylcystine Phase 4
11 Histamine Antagonists Phase 4
12 Histamine H1 Antagonists, Non-Sedating Phase 4
13 Anti-Allergic Agents Phase 4
14 Histamine H1 Antagonists Phase 4
15
Histamine Phosphate Phase 4 51-74-1 65513
16 Neurotransmitter Agents Phase 4
17
Dutasteride Approved, Investigational Phase 3 164656-23-9 152945 6918296
18 Pharmaceutical Solutions Phase 3
19
Nitric Oxide Approved Phase 1, Phase 2 10102-43-9 145068
20
Bimatoprost Approved, Investigational Phase 2 155206-00-1 5311027
21
Acetylcholine Approved, Investigational Phase 2 51-84-3 187
22
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
23
Vitamin C Approved, Nutraceutical Phase 1, Phase 2 50-81-7 5785 54670067
24
Maleic acid Experimental, Investigational Phase 1, Phase 2 110-17-8, 110-16-7 444972
25 Adjuvants, Immunologic Phase 2
26 Protective Agents Phase 2
27 Radiation-Protective Agents Phase 2
28 Antiviral Agents Phase 2
29 Ammonium trichloro(dioxoethylene-O,O'-)tellurate Phase 2
30 Respiratory System Agents Phase 1, Phase 2
31 Antioxidants Phase 1, Phase 2
32 Anti-Asthmatic Agents Phase 1, Phase 2
33 Endothelium-Dependent Relaxing Factors Phase 1, Phase 2
34 Bronchodilator Agents Phase 1, Phase 2
35
protease inhibitors Phase 2
36 HIV Protease Inhibitors Phase 2
37 Proteasome Inhibitors Phase 2
38 Androgens Phase 2
39 abobotulinumtoxinA Phase 2
40 Cholinergic Agents Phase 2
41 Botulinum Toxins Phase 2
42 Botulinum Toxins, Type A Phase 2
43 Ophthalmic Solutions Phase 2
44 Psychotropic Drugs Phase 2
45 Anticonvulsants Phase 2
46 Immunologic Factors Phase 1, Phase 2
47 Mitogens Phase 1, Phase 2
48 Complement Factor H Phase 1, Phase 2
49 Complement System Proteins Phase 1, Phase 2
50 Immunosuppressive Agents Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 126)
# Name Status NCT ID Phase Drugs
1 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
2 Minoxidil in Treatment of Androgenetic Alopecia Completed NCT04090801 Phase 4 Topical minoxidil 5% in 90% ethanol and 5% propylene glycol;Topical minoxidil 5% in pure ethanol alone
3 Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
4 the Effect of Adipose Derived Stem Cells Combined With Platelet Rich Plasma Versus Platelet Rich Plasma Alone on Follicular Unit Extraction Hair Transplantion in Male Androgenic Alopecia: Clinical Trial Recruiting NCT03388840 Phase 4
5 Efficacy and Tolerability of N-Acetyl- Cysteine for Treatment of The Early-onset Androgenetic Alopecia in Men Recruiting NCT04209803 Phase 4 Minoxidil 5% topically and oral NAC 600 mg
6 Topical Cetirizine Gel Versus Minoxidil 5% Gel in Treatment of Androgenetic Alopecia Not yet recruiting NCT04293822 Phase 4 Cetirizine;Minoxidil
7 The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia Withdrawn NCT02483195 Phase 4 5% Minoxidil;200mg Spironolactone;5mg Finasteride
8 BLIND RANDOMIZED COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MESOTHERAPY MINOXIDIL HAIR WITH 0.5% / 2ML VERSUS PLACEBO IN THE TREATMENT OF FEMALE ANDROGENETIC ALOPECIA Unknown status NCT01655108 Phase 3 Minoxidil;Saline
9 An Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Dutasteride 0.5mg Once Daily for 6 Months in the Treatment of Male Subjects With Androgenetic Alopecia (Norwood-Hamilton Classification Type IIIv, IV and V) Completed NCT00441116 Phase 3 Dutasteride 0.5mg oral tablets
10 Evaluating the Efficacy of Topical Herbal Solution on the Treatment of Androgenetic Alopecia and Comparison With Minoxidil 5%: A Double-Blind, Randomized, Clinical Trial Study Completed NCT03753113 Phase 3 Topical Herbal Solution;Topical Minoxidil 5%
11 A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia Completed NCT02014584 Phase 3 Dutasteride;Placebo
12 A Prospective, Randomized, Controlled, Double-Blind Study That Evaluates the Safety and Efficacy of Three Active REVIAN Caps Versus a Non-Active REVIAN Cap (Sham) in Participants With Pattern Hair Loss (Androgenic Alopecia) Completed NCT04019795 Phase 3
13 A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia Completed NCT00396175 Phase 3 MK0906, finasteride / Duration of Treatment : 48 Weeks;Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks
14 Investigator-initiated Single Blind, Two-armed, Randomized Phase 3 Clinical Trial to Compare Efficacy of 5% Minoxidil Topical Foam (5% Mtf) Once Daily Versus 2% Minoxidil Topical Solution (2% Mts) Twice Daily in Application on Females With Slightly to Moderate Androgenetic Alopecia Concerning Hair Volume Completed NCT00958750 Phase 3 minoxidil
15 Study ARI114264: A Long-Term Study of the Safety and Efficacy of Dutasteride in the Treatment of Male Subjects With Androgenetic Alopecia Completed NCT01831791 Phase 3 Dutasteride 0.5 mg
16 Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study Completed NCT01391156 Phase 3 3%Minoxidil lotion;3% Minoxidil with 0.1% Finasteride lotion
17 A Multicentre, Randomized, Double-blind, Parallel-group, Controlled Study, to Assess the Efficacy and Safety of P-3074 Cutaneous Spray, Solution, in the Treatment of Male Pattern Baldness Completed NCT03004469 Phase 3 P-3074;Finasteride;P-3074 Vehicle;Finasteride Placebo
18 A Study of the Efficacy and Safety of Multiple Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia Completed NCT01231607 Phase 3 1mg Finasteride active;0.02mg dutasteride;0.1mg dutasteride;0.5mg dutasteride;Finasteride placebo;Dutasteride placebo
19 A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males Completed NCT00151515 Phase 3 minoxidil
20 A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Completed NCT01226459 Phase 3 5% Minoxidil Topical Foam;Vehicle Topical Foam
21 A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5 % Minoxidil Foam vs. 2 % Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss - Androgenetic Alopecia (MINALO3004, NCT01145625) Completed NCT01145625 Phase 3 5% Minoxidil;2% Minoxidil
22 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 0.15% & 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia Active, not recruiting NCT03742518 Phase 2, Phase 3 Topical SM04554 solution;Topical SM04554 solution;Topical vehicle solution
23 Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women Unknown status NCT00418249 Phase 2 AS101
24 A Phase 2 Multicenter, Randomized, Placebo-Controlled, Parallel Group Dose-Ranging Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men Unknown status NCT00471510 Phase 2 tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
25 A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradome™ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia Unknown status NCT02528552 Phase 2
26 A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment Of Androgenetic Alopecia (AGA) Unknown status NCT01643629 Phase 1, Phase 2
27 The Clinical Effects of HSC (Hair Stimulating Complex) on Hair Growth in Androgenetic Alopecia: A Phase I/II Clinical Trial Unknown status NCT01501617 Phase 1, Phase 2
28 An Efficacy and Safety Pilot Study Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Treatment of AGA Unknown status NCT01650272 Phase 1, Phase 2 5% MInoxidil milky lotion;5% Minoxidil solution
29 A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate For Treatment Of Androgenetic Alopecia In Patients Undergoing Hair Transplant Unknown status NCT01644422 Phase 1, Phase 2
30 Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia Unknown status NCT01347957 Phase 1, Phase 2
31 A Randomised, Double-blind, Placebo-controlled Phase 2 Trial of FOL-005 to Investigate Efficacy on Hair Growth on Scalp Skin in Healthy Volunteers Unknown status NCT03467412 Phase 2 FOL-005;Placebo
32 Evaluation of the Efficacy of Hcap Formula Nutrition Supplement for Treatment of Men With Androgenic Alopecia: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Completed NCT02150187 Phase 2
33 A Phase 2, Multicenter, Randomized, Double-Blind Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia (AGA) Analyzed by Biopsy of the Scalp Prior To and Post Dosing Completed NCT02503137 Phase 2 Topical SM04554 solution;Topical Vehicle solution
34 A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia Completed NCT02280603 Phase 1, Phase 2 DA-4001C;5% minoxidil
35 A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA) Completed NCT02279823 Phase 2 CB-03-01 solution;Minoxidil Solution 5%;Placebo solution
36 A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle- Controlled Study of the Safety, Tolerability, and Efficacy of 0.15% and 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) Completed NCT02275351 Phase 2 SM04554;Vehicle
37 A Phase 2 Multicenter, Randomized, Placebo- and Comparator-Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men Completed NCT00418730 Phase 2 tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
38 A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia Completed NCT00965640 Phase 2 Botulinum Toxin - A injections
39 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males Completed NCT02781311 Phase 2 Setipiprant;Placebo;Finasteride
40 A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) Completed NCT01904721 Phase 2 Bimatoprost Solution 1;Bimatoprost Solution 2;Bimatoprost Vehicle
41 A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of ex Vivo-cultured, Expanded, Occipital Autologous Dermal and Epidermal Cells, Injected Into the Hair Loss Area of the Scalp of Male and Female Subjects With Alopecia Completed NCT01669746 Phase 2
42 A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects Completed NCT01451190 Phase 2
43 A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells, Where Cells Are Expanded ex Vivo From Plucked Scalp, Into the Hair Loss Area of the Scalp of Subjects. Completed NCT01451177 Phase 2
44 A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects Completed NCT01451151 Phase 2
45 A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells Into the Hair Loss Area of the Scalp of Subjects Completed NCT01451138 Phase 2
46 A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects and Synergy With Application of Topical Minoxidil Completed NCT01451125 Phase 2
47 A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects Completed NCT01451112 Phase 2
48 A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Completed NCT01451099 Phase 2
49 A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of a 1 Time Injection vs. Repeat Injections of ex Vivo Expanded Cultured Autologous Occipital Dermal and Epidermal Cells (Same Day as Cell Culture Harvest) Into the Balding Scalp of Subjects With Hair Loss Completed NCT01451073 Phase 2
50 A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Completed NCT01451047 Phase 2

Search NIH Clinical Center for Androgenic Alopecia

Genetic Tests for Androgenic Alopecia

Anatomical Context for Androgenic Alopecia

MalaCards organs/tissues related to Androgenic Alopecia:

40
Skin, Prostate, Ovary, Testes, Endothelial, Breast, Brain

Publications for Androgenic Alopecia

Articles related to Androgenic Alopecia:

(showing 1816, show less)
# Title Authors PMID Year
1
A comprehensive review of biochemical factors in herbs and their constituent compounds in experimental studies on alopecia. 61
32360043 2020
2
LC-MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin. 61
32473548 2020
3
Herbal preparations for the treatment of hair loss. 61
31680216 2020
4
Accelerated hair growth by combining thread monofilament and minoxidil in female androgenetic alopecia. 61
31789457 2020
5
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19? 61
32333494 2020
6
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm. 61
32202088 2020
7
Correction to: Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study. 61
32350810 2020
8
Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway. 61
32412314 2020
9
Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. 61
32538225 2020
10
The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis. 61
32166351 2020
11
Comparative Study to Evaluate Tolerability of Topical 5% Minoxidil Novel Formulation and Alcohol-Based Conventional Solutions in Treatment of Androgenetic Alopecia in Indian Men: Randomized Double-Blind Study. 61
32277388 2020
12
Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report. 61
32500595 2020
13
Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function. 61
32052367 2020
14
The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis. 61
32478968 2020
15
Clinical experience on follicular unit extraction megasession for severe androgenetic alopecia. 61
31529675 2020
16
Cross Sectional Quality of Life Assessment in Patients with Androgenetic Alopecia. 61
32520416 2020
17
Study of serum vitamin D levels in men with premature androgenetic alopecia. 61
32516435 2020
18
Evaluation of quality of life of patients with hirsutism among Turkish women: A single-center cross-sectional study. 61
32564506 2020
19
Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism. 61
32571540 2020
20
The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia. 61
32378360 2020
21
Finasteride and androgenic alopecia; from therapeutic options to medical implications. 61
30897009 2020
22
Does Estradiol Level in Platelet-Rich Plasma Improve Efficacy of Androgenic Alopecia Treatment? 61
32511689 2020
23
Platelet-Rich Plasma and its Use for Cicatricial and Non-Cicatricial Alopecias: A Narrative Review. 61
32557337 2020
24
Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use. 61
32469180 2020
25
Erosive pustular dermatosis of the scalp: a multicentre study. 61
31954062 2020
26
Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. 61
32516434 2020
27
Erosive pustular dermatosis of the scalp: causes and treatments. 61
32516510 2020
28
A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women. 61
31574029 2020
29
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report. 61
32503484 2020
30
Donor site of follicular unit excision hair transplantation: the relationship between appearance and actual hair density, and hair diameter. 61
32093524 2020
31
Global expression profile and global genome methylation signatures in male patients with androgenetic alopecia. 61
31876348 2020
32
Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign". 61
32446821 2020
33
Efficacy and safety of very low dose oral minoxidil 1.25mg in male androgenetic alopecia. 61
32492469 2020
34
Progenitor-cell-enriched micrografts as a novel option for the management of androgenetic alopecia. 61
31643084 2020
35
Cell Enriched Autologous Fat Grafts to Follicular Niche Improves Hair Regrowth in Early Androgenetic Alopecia. 61
32020170 2020
36
MR Imaging of Hair and Scalp for the Evaluation of Androgenetic Alopecia. 61
32378681 2020
37
RF-Mesotherapy With Dutasteride: A Future Alternative Treatment for Androgenetic Alopecia. 61
32416936 2020
38
Stromal vascular fraction-enriched platelet-rich plasma therapy reverses the effects of androgenetic alopecia. 61
31541565 2020
39
Dexpanthenol may be a novel treatment for male androgenetic alopecia: Analysis of nine cases. 61
32255530 2020
40
5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. 61
32279398 2020
41
Clascoterone as a novel treatment for androgenetic alopecia. 61
32421862 2020
42
Androgenetic alopecia is associated with increased scalp hardness. 61
31944388 2020
43
A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. 61
32420695 2020
44
Investigation of optimum transplant and extraction density based on the data from the donor area of Chinese androgenetic alopecia patients: a multicenter, retrospective study. 61
32375571 2020
45
At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors. 61
32382642 2020
46
A randomized, single-blinded, vehicle-controlled study of a topical active blend in the treatment of androgenetic alopecia. 61
32473084 2020
47
Efficacy of Platelet Rich Plasma Intradermal Injections for Androgenetic Alopecia Treatment in Males: A Before and After Study. 61
32401718 2020
48
Platelet-rich plasma injections in the treatment of male androgenetic alopecia: A randomized placebo-controlled crossover study. 61
31532574 2020
49
Plasma Zinc Levels in Males with Androgenetic Alopecia as Possible Predictors of the Subsequent Conservative Therapy's Effectiveness. 61
32456296 2020
50
Novel topical booster enhances follicular sulfotransferase activity in patients with androgenetic alopecia: a new strategy to improve minoxidil response. 61
32432358 2020
51
Polygonum multiflorum extract support hair growth by elongating anagen phase and abrogating the effect of androgen in cultured human dermal papilla cells. 61
32398000 2020
52
Platelet-Rich Plasma for Hair Restoration. 61
32312505 2020
53
Post-finasteride syndrome. 61
32317131 2020
54
Macular Abnormalities Associated With 5α-Reductase Inhibitor. 61
32379286 2020
55
Current advances in stem cell-based therapies for hair regeneration. 61
32439260 2020
56
Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature. 61
32536461 2020
57
Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti-inflammatory and antioxidant agents to treat hair loss. 61
32134172 2020
58
The use of phosphodiesterase inhibitors for the treatment of alopecia. 61
30935254 2020
59
Getting under the skin of hair aging: the impact of the hair follicle environment. 61
32358903 2020
60
Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis. 61
32410524 2020
61
Post-finasteride syndrome: An emerging clinical problem. 61
32435662 2020
62
Physiology and Medical Treatments for Alopecia. 61
32312501 2020
63
Androgen sensitivity gateway to COVID-19 disease severity. 61
32412125 2020
64
Migration Inhibitory Factor in Conditioned Medium from Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells Stimulates Hair Growth. 61
32481584 2020
65
Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates. 61
31981690 2020
66
Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis. 61
32446820 2020
67
Expanding Clinical Indications of Mechanically Isolated Stromal Vascular Fraction: A Systematic Review. 61
32358957 2020
68
Vanillic Acid Stimulates Anagen Signaling via the PI3K/Akt/β-Catenin Pathway in Dermal Papilla Cells. 61
32394669 2020
69
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy. 61
32295047 2020
70
What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. 61
32237190 2020
71
Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population. 61
32275116 2020
72
Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality. 61
32250713 2020
73
A review of the treatment of male pattern hair loss 61
32066284 2020
74
Recurring transient lymphadenopathy after microneedling with platelet-rich plasma for androgenetic alopecia. 61
32278805 2020
75
Hyperuricemia is associated with androgenetic alopecia in men: A cross-sectional case-control study. 61
32281237 2020
76
Comment on 'Androgenetic alopecia is associated with increased scalp hardness': role of phosphodiesterase inhibitors? 61
32335955 2020
77
Stratifying clinical response to adjuvant platelet-rich plasma in patients with androgenetic alopecia. 61
32248528 2020
78
The Effect of Intradermal Botulinum Toxin on Androgenetic Alopecia and Its Possible Mechanism. 61
32339707 2020
79
5α-reductase inhibitors in men aged 50 years or older with androgenetic alopecia: a retrospective study. 61
32320771 2020
80
Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. 61
31832993 2020
81
Androgenetic Alopecia in Gender Minority Patients. 61
32115134 2020
82
The effect of 1540-nm fractional erbium-glass laser in the treatment of androgenic alopecia. 61
31524330 2020
83
QR 678 & QR678 Neo Vs PRP-A randomised, comparative, prospective study. 61
32333510 2020
84
New effects of caffeine on corticotropin-releasing hormone (CRH)-induced stress along the intrafollicular classical hypothalamic-pituitary-adrenal (HPA) axis (CRH-R1/2, IP3 -R, ACTH, MC-R2) and the neurogenic non-HPA axis (substance P, p75NTR and TrkA) in ex vivo human male androgenetic scalp hair follicles. 61
32271938 2020
85
The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part II: Clinical Evidence. 61
31770154 2020
86
Autologous platelet-rich plasma therapy for pattern hair loss: A systematic review. 61
31452328 2020
87
Impact of dutasteride on spermatogenesis and oxidative status in rats. 61
32240114 2020
88
Theoretical basis and clinical practice for FUE megasession hair transplantation in the treatment of large area androgenic alopecia. 61
32346966 2020
89
Relationship between androgenic alopecia and white matter hyperintensities in apparently healthy subjects. 61
31250269 2020
90
Androgenetic alopecia; An attempt to target microinflammation. 61
32052538 2020
91
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. 61
31733195 2020
92
Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. 61
32492993 2020
93
Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk. 61
32258059 2020
94
Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort. 61
32188323 2020
95
Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia. 61
32162134 2020
96
Androgenetic alopecia-Perspective from patients in a Singaporean tertiary Dermatology center. 61
32185827 2020
97
Severity of androgenetic alopecia associated with poor sleeping habits and carnivorous eating and junk food consumption-A web-based investigation of male pattern hair loss in China. 61
32061036 2020
98
Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia. 61
32011196 2020
99
Effective combination therapy with high concentration of Minoxidil and Carboxygas in resistant Androgenetic alopecia: Report of nine cases. 61
32162774 2020
100
Growth factor concentrations in platelet-rich plasma for androgenetic alopecia: An intra-subject, randomized, blinded, placebo-controlled, pilot study. 61
31984508 2020
101
Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia. 61
31741401 2020
102
Vascular Endothelial Growth Factor Protects CD200-Rich and CD34-Positive Hair Follicle Stem Cells Against Androgen-Induced Apoptosis Through the Phosphoinositide 3-Kinase/Akt Pathway in Patients With Androgenic Alopecia. 61
31478937 2020
103
Cholesterol homeostasis: Links to hair follicle biology and hair disorders. 61
31260136 2020
104
The Role of Diet as an Adjuvant Treatment in Scarring and Nonscarring Alopecia. 61
32258051 2020
105
Treatment of Male-Pattern Alopecia with Platelet-Rich Plasma. 61
32258052 2020
106
Extract of Plumbago zeylanica enhances the growth of hair follicle dermal papilla cells with down-regulation of 5α-reductase type II. 61
32125089 2020
107
The Physician's Guide to Platelet-Rich Plasma in Dermatologic Surgery Part I: Definitions, Mechanisms of Action, and Technical Specifications. 61
31714381 2020
108
Monofilament threads in treatment of female hair loss. 61
31619089 2020
109
Preliminary results of the use of scalp microneedling in different types of alopecia. 61
31254437 2020
110
Platelet-Rich Plasma and Stem Cells for Hair Growth: A Review of the Literature. 61
31111157 2020
111
Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration. 61
32171310 2020
112
Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors. 61
32008083 2020
113
PPAR-γ signalling as a key mediator of human hair follicle physiology and pathology. 61
31769892 2020
114
Large-Scale Beard Extraction Enhances the Cosmetic Results of Scalp Hair Restoration in Advanced Androgenetic Alopecia in East Asian Men: A Retrospective Study. 61
31784942 2020
115
Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy. 61
29580860 2020
116
Platelet-rich plasma associated with hair transplants for the treatment of androgenetic alopecia showed no benefits. 61
32103552 2020
117
Female Androgenetic Alopecia: An Update on Diagnosis and Management. 61
31677111 2020
118
The impact of oxidative stress in androgenic alopecia in women. 61
32489344 2020
119
Ultrasound-activated particles as CRISPR/Cas9 delivery system for androgenic alopecia therapy. 61
31901692 2020
120
Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women. 61
31967291 2020
121
'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries. 61
31465592 2020
122
Trichoscopic evaluation of frontal hairline recession in Egyptian female patients. 61
32048427 2020
123
Can we halt male androgenetic alopecia progression without antiandrogenic drugs? 61
31846191 2020
124
Oral Minoxidil: A Possible New Therapy for Androgenetic Alopecia. 61
31994933 2020
125
Exosomes: A New Effective Non-Surgical Therapy for Androgenetic Alopecia? 61
32501792 2020
126
Androgenetic Alopecia: Relationship to Anthropometric Indices, Blood Pressure and Life-Style Habits. 61
32104040 2020
127
Do Kimchi and Cheonggukjang Probiotics as a Functional Food Improve Androgenetic Alopecia? A Clinical Pilot Study. 61
31385480 2020
128
The Clinical Efficacy and Safety of Autologous Activated Platelet-Rich Plasma Injection in Androgenetic Alopecia. 61
32021857 2020
129
Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia. 61
31066492 2020
130
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. 61
31858672 2020
131
Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation. 61
31520662 2020
132
A prospective study examining isolated acne and acne with hyperandrogenic signs in adult females. 61
31868042 2020
133
Formononetin: Novel Deal for Androgenetic Alopecia. 61
32086106 2020
134
Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? 61
32148484 2020
135
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution. 61
32023218 2020
136
The Effect of the Fractional Carbon Dioxide Laser on Improving Minoxidil Delivery for the Treatment of Androgenetic Alopecia. 61
32099624 2020
137
Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia. 61
32071919 2020
138
Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study. 61
31820540 2020
139
Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia. 61
29028377 2020
140
Reply to: "Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation". 61
31520659 2020
141
Fibrosing alopecia in a pattern distribution. 61
31926219 2020
142
Increased Preauricular Wrinkles in Frontal Fibrosing Alopecia Compared to Age-Matched Controls: A Prospective Study of 64 Patients. 61
32021855 2020
143
Human Derived Immortalized Dermal Papilla Cells With a Constant Expression of Testosterone Receptor. 61
32269992 2020
144
Isolating Dermal Papilla Cells from Human Hair Follicles Using Microdissection and Enzyme Digestion. 61
32314210 2020
145
Types and Treatment of Hair Loss in Men and Women. 61
32102074 2020
146
Platelet-Rich Plasma and Its Utilities in Alopecia: A Systematic Review. 61
31211715 2020
147
Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata. 61
32411613 2020
148
Post-finasteride syndrome: a surmountable challenge for clinicians. 61
32033719 2020
149
Standardization of Plasma Rich in Growth Factors (PRGF) and its effects on androgenic hair loss. 61
31838924 2020
150
Finasteride and Suicide: A Postmarketing Case Series. 61
31935720 2020
151
Extremely Low-Frequency Electromagnetic Fields Increase the Expression of Anagen-Related Molecules in Human Dermal Papilla Cells via GSK-3β/ERK/Akt Signaling Pathway. 61
31991762 2020
152
Platelet sonicates activate hair follicle stem cells and mediate enhanced hair follicle regeneration. 61
31802614 2020
153
In silico analysis of gene expression data from bald frontal and haired occipital scalp to identify candidate genes in male androgenetic alopecia. 61
31511972 2019
154
A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia. 61
30982177 2019
155
Dilation of Multiple Eccrine Ducts as a Highly Specific Marker for Cicatricial Alopecia. 61
31764231 2019
156
The effect of platelet-rich plasma injection in the treatment of androgenetic alopecia. 61
30895745 2019
157
Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia. 61
31689460 2019
158
Non-ablative radio frequency for the treatment of androgenetic alopecia. 61
31855270 2019
159
Post-finasteride syndrome - does it really exist? 61
30651009 2019
160
The mechanism of activated platelet-rich plasma supernatant promotion of hair growth by cultured dermal papilla cells. 61
30884113 2019
161
In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole. 61
31835695 2019
162
Meta-analysis of photobiomodulation for the treatment of androgenetic alopecia. 61
31746251 2019
163
Alopecia areata multiplex following autologous dermal micrograft injection for treatment of androgenetic alopecia. 61
31120162 2019
164
The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility. 61
31168786 2019
165
[Therapeutic effect of Impatiens balsamina, Lawsonia inermis L. and Henna on androgenetic alopecia in mice]. 61
31852654 2019
166
A Study of Correlation of Angiographic Evaluation of Coronary Artery Disease with Androgenetic Alopecia - TricoHeart Study. 61
32030055 2019
167
Altered polyamine profiling in the hair of patients with androgenic alopecia and alopecia areata. 61
31464015 2019
168
Amyloid-Associated Alopecia: A Reappraisal Including Its Pathophysiology. 61
30839340 2019
169
Mechanism of androgenic alopecia: Addressing speculations through empirical evidences. 61
31614040 2019
170
Types of hairline recession in androgenetic alopecia and perceptions of aging in Asian males. 61
30888056 2019
171
Hair distribution width - a novel trichoscopy parameter for hair miniaturization in androgenetic alopecia. 61
31066933 2019
172
Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia. 61
30882509 2019
173
Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. 61
31403367 2019
174
Platelet-Rich Plasma for Treating Androgenic Alopecia: A Systematic Review. 61
31187167 2019
175
Approach to Hair Transplantation in Advanced Grade Baldness by Follicular Unit Extraction: A Retrospective Analysis of 820 Cases. 61
32001965 2019
176
Reproductive endocrinologists are the gatekeepers for male infertility care in North America: results of a North American survey on the referral patterns and characteristics of men presenting to male infertility specialists for infertility investigations. 61
31351700 2019
177
Phospholipid-polymer hybrid nanoparticle-mediated transfollicular delivery of quercetin: prospective implement for the treatment of androgenic alopecia. 61
31382790 2019
178
Quantitative proteomic analysis of dermal papilla from male androgenetic alopecia comparing before and after treatment with low-level laser therapy. 61
30843235 2019
179
Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options. 61
31456448 2019
180
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens. 61
31400254 2019
181
Platelet-Rich Plasma Therapy for Androgenetic Alopecia. 61
31543541 2019
182
Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades. 61
31228018 2019
183
Pediatric androgenetic alopecia: A review. 61
31415838 2019
184
Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. 61
31559256 2019
185
Investigation on Microecology of Hair Root Fungi in Androgenetic Alopecia Patients. 61
31240449 2019
186
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. 61
31054970 2019
187
Efficacy of platelet-rich plasma in androgenetic alopecia patients. 61
30393988 2019
188
Androgenetic alopecia and microneedling: Every needling is not microneedling. 61
30905794 2019
189
An overview of herbal alternatives in androgenetic alopecia. 61
30980598 2019
190
Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled trial. 61
30569416 2019
191
Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia. 61
30252550 2019
192
The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future. 61
30300013 2019
193
Erosive pustular dermatosis of the scalp: A neutrophilic folliculitis within the spectrum of neutrophilic dermatoses: A clinicopathologic study of 30 cases. 61
30617027 2019
194
Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness? 61
31559258 2019
195
Distinguishing Lipedematous Scalp, Lipedematous Alopecia, and Diffuse Alopecia Areata. 61
31559257 2019
196
Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials. 61
30706177 2019
197
Expression of anti-aging type-XVII collagen (COL17A1/BP180) in hair follicle-associated pluripotent (HAP) stem cells during differentiation. 61
31383286 2019
198
Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study. 61
31272082 2019
199
Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey-based, single-centre, controlled study. 61
30835851 2019
200
Photographic assessment improves adherence to recommended follow-up in patients with androgenetic alopecia and alopecia areata: A retrospective cohort study. 61
31062723 2019
201
Generation of an integration-free human induced pluripotent stem cell line MUSIi010-A from occipital scalp fibroblasts of a male patient with androgenetic alopecia. 61
31228683 2019
202
Letter in response to "The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia". 61
30880717 2019
203
A small dose of botulinum toxin A is effective for treating androgenetic alopecia in Chinese patients. 61
30566260 2019
204
Quality of Life Assessment in Patients with Androgenetic Alopecia. 61
31523105 2019
205
Histopathology of aging of the hair follicle. 61
30932205 2019
206
Biofibre® artificial hair implant: Retrospective study on 1,518 patients with alopecia and present role in hair surgery. 61
31168904 2019
207
Long-term treatment with finasteride induces apoptosis and pathological changes in female mice. 61
30943778 2019
208
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. 61
30785992 2019
209
Finasteride Enhances Stem Cell Signals of Human Dermal Papilla Cells. 61
31280211 2019
210
Autologous Cellular Method Using Micrografts of Human Adipose Tissue Derived Follicle Stem Cells in Androgenic Alopecia. 61
31337037 2019
211
Adipose Infiltration of the Dermis, Involving the Arrector Pili Muscle, and Dermal Displacement of Eccrine Sweat Coils: New Histologic Observations in Frontal Fibrosing Alopecia. 61
30624243 2019
212
Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia. 61
31217429 2019
213
Herbal Medicines For Treatment of Androgenic Alopecia. 61
31221945 2019
214
Harvested vs estimated follicular units in hair transplantation. 61
30084223 2019
215
Fibrosing Alopecia in a Pattern Distribution (FAPD) in 16 African-Descent and Hispanic Female Patients: A Challenging Diagnosis. 61
31367598 2019
216
Development of finasteride polymer microspheres for systemic application in androgenic alopecia. 61
30942390 2019
217
Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. 61
30974011 2019
218
Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia. 61
30209896 2019
219
Correlation of Trichoscopic Findings in Androgenetic Alopecia and the Disease Severity. 61
31360040 2019
220
A semiquantitative grading scale for frontal and vertex of androgenetic alopecia. 61
30592306 2019
221
Prostaglandins in androgenetic alopecia in 12 men and four female. 61
30730082 2019
222
Platelet rich plasma in androgenetic alopecia: A systematic review. 61
30667146 2019
223
Expert consensus on the management of Androgenetic Alopecia in India. 61
31360037 2019
224
Vitamin D and the Skin: A Review for Dermatologists. 61
30857638 2019
225
Premature Desquamation of the Inner Root Sheath in Noninflamed Hair Follicles as a Specific Marker for Central Centrifugal Cicatricial Alopecia. 61
30562220 2019
226
Faster calculation of scalp area in androgenetic alopecia before Platelet Rich Plasma therapy using a mobile application imagemeterTM. 61
31153948 2019
227
Identification of the sulfotransferase iso-enzyme primarily responsible for the bio-activation of topical minoxidil. 61
31184104 2019
228
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development. 61
31100937 2019
229
Bacillus/Trapa japonica Fruit Extract Ferment Filtrate enhances human hair follicle dermal papilla cell proliferation via the Akt/ERK/GSK-3β signaling pathway. 61
31088549 2019
230
Bold to do - bald to be? Outcomes decades after harvesting the scalp in burned children. 61
30337156 2019
231
Familial frontal fibrosing alopecia: A cross-sectional study of 20 cases from nine families. 61
30430555 2019
232
The Trichoscopy Derived Sinclair Scale: Enhancing visual assessment through quantitative trichoscopy. 61
30565210 2019
233
Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study. 61
31100850 2019
234
What's New in Hair Loss. 61
30850035 2019
235
Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Re-Growth in Androgenetic Alopecia. Biomolecular Pathway Analysis and Clinical Evaluation. 61
30965624 2019
236
The Higher Number and Longer Duration of Kenogen Hairs Are the Main Cause of the Hair Rarefaction in Androgenetic Alopecia. 61
31049336 2019
237
Acne development in male androgenetic alopecia. 61
30499125 2019
238
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors. 61
30301703 2019
239
Off-Label Use of Topical Minoxidil in Alopecia: A Review. 61
30604379 2019
240
Platelet rich plasma for the management of hair loss: Better alone or in combination? 61
29904992 2019
241
Laser-assisted Hair Regrowth: Fractional Laser Modalities for the Treatment of Androgenic Alopecia. 61
31321172 2019
242
The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics-A Systematic Review and Meta-analysis. 61
30606055 2019
243
Controversies in the treatment of androgenetic alopecia: The history of finasteride. 61
30253001 2019
244
Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review. 61
30652260 2019
245
A Study to Compare the Efficacy of Platelet-rich Plasma and Minoxidil Therapy for the Treatment of Androgenetic Alopecia. 61
31007475 2019
246
HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. 61
30394586 2019
247
Comparative Study between Mesotherapy and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Male: A Randomized Controlled Trial. 61
31007474 2019
248
New drugs under investigation for the treatment of alopecias. 61
30642204 2019
249
Treatment of male pattern alopecia with platelet-rich plasma: A double-blind controlled study with analysis of platelet number and growth factor levels. 61
30287324 2019
250
Evaluating hair growth promoting effects of candidate substance: A review of research methods. 61
30904351 2019
251
Self-Assessments of Standardized Scalp Massages for Androgenic Alopecia: Survey Results. 61
30671883 2019
252
The role of photobiomodulation when associated with microneedling in female pattern hair loss: A randomized, double blind, parallel group, three arm, clinical study protocol. 61
30896659 2019
253
Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study. 61
29659116 2019
254
Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma - with or without concurrent bimatoprost and/or minoxidil. 61
30865404 2019
255
Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system. 61
30536893 2019
256
Platelet-rich plasma on female androgenetic alopecia: Tested on 10 patients. 61
29707872 2019
257
Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients. 61
30640755 2019
258
Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol. 61
30809579 2019
259
Serum biotin and zinc in male androgenetic alopecia. 61
30714301 2019
260
Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors. 61
30575417 2019
261
Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. 61
30830894 2019
262
Distinguishing immunohistochemical features of alopecia areata from androgenic alopecia. 61
29790258 2019
263
Cortexolone 17α-Propionate (Clascoterone) is an Androgen Receptor Antagonist in Dermal Papilla Cells In Vitro 61
30811143 2019
264
The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review 61
30794366 2019
265
Review of Human Hair Follicle Biology: Dynamics of Niches and Stem Cell Regulation for Possible Therapeutic Hair Stimulation for Plastic Surgeons. 61
30324295 2019
266
[Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Zalecenia dotyczące postępowania niefarmakologicznego u kobiet z PCOS celem zmniejszenia masy ciała i poprawy zaburzeń metabolicznych]]. 61
31039273 2019
267
Menopausal Acne - Challenges And Solutions. 61
31754313 2019
268
Metabolic Syndrome and Skin Diseases. 61
31824416 2019
269
Microbiome in the hair follicle of androgenetic alopecia patients. 61
31050675 2019
270
Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia. 61
31525235 2019
271
The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study. 61
30745631 2019
272
Insights into Male Androgenetic Alopecia: Differential Gene Expression Profiling of Plucked Hair Follicles and Integration with Genetic Data. 61
30009830 2019
273
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. 61
30206635 2019
274
Meta-Analysis on the Efficacy and Safety of Traditional Chinese Medicine as Adjuvant Therapy for Refractory Androgenetic Alopecia. 61
31781285 2019
275
The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia. 61
31949455 2019
276
The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. 61
30863034 2019
277
Telogen effluvium: a comprehensive review. 61
31686886 2019
278
Minoxidil and its use in hair disorders: a review. 61
31496654 2019
279
Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition. 61
30265917 2019
280
Erosive pustular dermatosis of the scalp: challenges and solutions. 61
31571969 2019
281
Correlation between Clinical Features, Biochemical Parameters, and Histopathological Findings in Women with Patterned Baldness: A Study from North India. 61
31057268 2019
282
Jagged1 and Epidermal Growth Factor Promoted Androgen-Suppressed Mouse Hair Growth In Vitro and In Vivo. 61
32082154 2019
283
Platelet-Rich Plasma and Genital Rejuvenation. 61
31627791 2019
284
Assessment of Safe Donor Zone of Scalp and Beard for Follicular Unit Extraction in Indian Men: A Study of 580 Cases. 61
31057266 2019
285
Autistic-Undisciplined Thinking in the Practice of Medical Trichology. 61
30820126 2019
286
A Study of the Histopathological Features of Alopecias on Transverse Sections of Scalp Biopsies. 61
30745635 2019
287
Platelet-rich plasma and microneedling improves hair growth in patients ofandrogenetic alopecia when used as an adjuvant to minoxidil. 61
30693667 2019
288
Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy. 61
30248187 2019
289
Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms. 61
31011438 2019
290
Clinical Profile of Androgenic Alopecia and Its Association with Cardiovascular Risk Factors. 61
30745630 2019
291
A liposome-based formulation containing equol, dihomo-γ-linolenic acid and propionyl-l-carnitine to prevent and treat hair loss: A prospective investigation. 61
30371981 2019
292
Thiosulfate promotes hair growth in mouse model. 61
30200826 2019
293
The new paradigm for androgenetic alopecia and plant-based folk remedies: 5α-reductase inhibition, reversal of secondary microinflammation and improving insulin resistance. 61
30195058 2018
294
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. 61
29972712 2018
295
The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia. 61
30520225 2018
296
Dermoscopic pre- and posttreatment evaluation in patients with androgenetic alopecia on platelet-rich plasma-A prospective study. 61
30556270 2018
297
The relationship between self-esteem and hair transplantation satisfaction in male androgenetic alopecia patients. 61
30582267 2018
298
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. 61
29797431 2018
299
Platelet-Rich Plasma for the Treatment of Androgenic Alopecia: A Systematic Review. 61
29954021 2018
300
Association of Hair Loss With Health Utility Measurements Before and After Hair Transplant Surgery in Men and Women. 61
30242313 2018
301
Study of the efficacy of carboxytherapy in alopecia. 61
29460509 2018
302
Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit. 61
29087225 2018
303
Over-the-Counter Hair Loss Treatments: Help or Hype? 61
30586264 2018
304
Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. 61
30226287 2018
305
Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss. 61
29452017 2018
306
Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial. 61
29957664 2018
307
New-Onset Androgenic Alopecia following Human Chorionic Gonadotropic Diet and Testosterone Pellet Implantation. 61
30783337 2018
308
Establishment of an in vitro organoid model of dermal papilla of human hair follicle. 61
29923313 2018
309
Preformulation studies of finasteride to design matrix systems for topical delivery. 61
30176524 2018
310
A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia. 61
30886475 2018
311
Efficacy of 1,550-nm Erbium-Glass Fractional Laser Treatment and Its Effect on the Expression of Insulin-Like Growth Factor 1 and Wnt/β-Catenin in Androgenetic Alopecia. 61
30096107 2018
312
Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness? 61
29237093 2018
313
White and yellow dots as new trichoscopic signs of severe female androgenetic alopecia in dark skin phototypes. 61
30043983 2018
314
Evaluation of the Expression of Genes Associated with Inflammation and Apoptosis in Androgenetic Alopecia by Targeted RNA-Seq. 61
30410894 2018
315
Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia. 61
29790267 2018
316
Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe? 61
30410915 2018
317
Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. 61
30169980 2018
318
Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men. 61
30376555 2018
319
Injectable Platelet-, Leukocyte-, and Fibrin-Rich Plasma (iL-PRF) in the Management of Androgenetic Alopecia. 61
30045107 2018
320
Comparison of quality of life in patients with androgenetic alopecia and alopecia areata. 61
30156613 2018
321
Synergistic effect of platelet-rich plasma injections and scalp lifting in androgenetic alopecia. 61
30217282 2018
322
Minoxidil in the treatment of androgenetic alopecia. 61
30155952 2018
323
Estimation of Zinc and Iron Levels in the Serum and Hair of Women with Androgenetic Alopecia: Case-control Study. 61
30210156 2018
324
The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. 61
30027912 2018
325
Bayesian measurement-error-driven hidden Markov regression model for calibrating the effect of covariates on multistate outcomes: Application to androgenetic alopecia. 61
29785802 2018
326
Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial. 61
30141776 2018
327
Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: Design, characterization and clinical appraisal. 61
29981403 2018
328
Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms. 61
30208587 2018
329
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version. 61
29863806 2018
330
A bald statement - Current approaches to manipulate miniaturisation focus only on promoting hair growth. 61
29787625 2018
331
Translation into Portuguese language (Brazil), transcultural adaptation and validation of the quality of life questionnaire in female pattern hair loss (WAA-QoL-BP). 61
30156620 2018
332
Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I. 61
29740659 2018
333
Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. 61
27553744 2018
334
Efficacy and Safety of a Topical Botanical in Female Androgenetic Alopecia: A Randomized, Single-Blinded, Vehicle-Controlled Study. 61
30197894 2018
335
Automated digital image analysis (TrichoScan) in male patients with androgenetic alopecia; comparison with manual marking of hairs on trichoscopic images. 61
29363174 2018
336
Psychological assessment in 355 Chinese college students with androgenetic alopecia. 61
30075498 2018
337
Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin? 61
29675596 2018
338
Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in children. 61
29588248 2018
339
Perception of Hair Loss and Education Increases the Treatment Willingness in Patients With Androgenetic Alopecica: A Population-Based Study. 61
30065579 2018
340
Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review. 61
29227728 2018
341
Systematic review of low-level laser therapy for adult androgenic alopecia. 61
29286826 2018
342
Alopecia due to high androgen index contraceptives. 61
29979329 2018
343
Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia. 61
29549490 2018
344
New Perspectives on the Treatment of Androgenetic Alopecia. 61
29801692 2018
345
Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia. 61
29667763 2018
346
Androgenetic Alopecia Treatment in Asian Men. 61
30057663 2018
347
Naked Hair Shafts as a Marker of Cicatricial Alopecia. 61
29293128 2018
348
Impact on Quality of Life in Patients who came with Androgenetic Alopecia for Hair Transplantion Surgery in a Clinic. 61
30387465 2018
349
Introducing Platelet-Rich Stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) Combined for the Treatment of Androgenetic Alopecia. 61
29554209 2018
350
iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice. 61
29763605 2018
351
Naturally Occurring Hair Growth Peptide: Water-Soluble Chicken Egg Yolk Peptides Stimulate Hair Growth Through Induction of Vascular Endothelial Growth Factor Production. 61
29583066 2018
352
Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study. 61
29656764 2018
353
Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer. 61
30280054 2018
354
Medical comorbidities in patients with lichen planopilaris, a retrospective case-control study. 61
29682736 2018
355
Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions. 61
30002324 2018
356
Platelet-rich plasma for androgenic alopecia treatment: A comprehensive review. 61
30261560 2018
357
Photobiomodulation therapy for androgenetic alopecia: A clinician's guide to home-use devices cleared by the Federal Drug Administration. 61
29020478 2018
358
Is there a pathogenetic link between frontal fibrosing alopecia, androgenetic alopecia and fibrosing alopecia in a pattern distribution? 61
29224248 2018
359
Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation. 61
28771982 2018
360
Recycling of Previously Transplanted Hair: A Novel Indication for Follicular Unit Extraction. 61
29983809 2018
361
A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. 61
29945259 2018
362
Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China. 61
28940857 2018
363
Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29. 61
29853767 2018
364
Digit ratio 2D:4D is a possible indicator for androgenetic alopecia in males. 61
28856798 2018
365
Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride. 61
29574572 2018
366
Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies. 61
29707969 2018
367
Response to the letter to the editor; Androgenetic alopecia; drug safety and therapeutic strategies. 61
29707983 2018
368
Validation of a Cross-cultural Adaptation of the Hair Specific Skindex-29 Scale to Spanish. 61
29548490 2018
369
An unusual circulating steroid profile in a virilized postmenopausal woman. 61
29752879 2018
370
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer. 61
29641806 2018
371
Mechanical forces in skin disorders. 61
29567352 2018
372
Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth. 61
29554482 2018
373
Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome. 61
29875531 2018
374
Evaluating Platelet-Rich Therapy for Facial Aesthetics and Alopecia: A Critical Review of the Literature. 61
29697605 2018
375
Genetic and molecular aspects of androgenetic alopecia. 61
29595184 2018
376
[Injection of PRP (Platelet-rich plasma) as a treatment for androgenetic alopecia : a systematic review of the literature]. 61
29869472 2018
377
Minoxidil Downregulates Interleukin-1 Alpha Gene Expression in HaCaT Cells. 61
30034189 2018
378
Effects of 5-alpha reductase inhibitors: new insights on benefits and harms. 61
29528971 2018
379
Preservation of stem cells in androgenetic alopecia. 61
29055061 2018
380
Androgenetic alopecia; drug safety and therapeutic strategies. 61
29363345 2018
381
Identification of Functional Patterns of Androgenetic Alopecia Using Transcriptome Profiling in Distinct Locations of Hair Follicles. 61
29122575 2018
382
Medical Comorbidities and the Onset of Androgenetic Alopecia: A Population-Based, Case-Control Study. 61
29606834 2018
383
A Systematic Review of Topical Finasteride in the Treatment of Androgenetic Alopecia in Men and Women. 61
29601622 2018
384
Hairline Restoration: Difference in Men and Woman-Length and Shape. 61
29631285 2018
385
Proprietary Herbal Extract Downregulates the Gene Expression of IL-1α in HaCaT Cells: Possible Implications Against Nonscarring Alopecia. 61
30302033 2018
386
Microneedling for the treatment of hair loss? 61
29194786 2018
387
Determination of finasteride and its metabolite in urine by dispersive liquid-liquid microextraction combined with field-enhanced sample stacking and sweeping. 61
29534820 2018
388
Androgens and androgen receptor action in skin and hair follicles. 61
28912032 2018
389
Elastic Staining in Differentiating Between Follicular Streamers and Follicular Scars in Horizontal Scalp Biopsy Sections. 61
28816743 2018
390
Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic alopecia. 61
29512972 2018
391
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. 61
28604133 2018
392
The tendency towards the development of psychosexual disorders in androgenetic alopecia according to the different stages of hair loss: a cross-sectional study. 61
29723381 2018
393
Association of Androgenetic Alopecia with Metabolic Syndrome: A Case-control Study on 100 Patients in a Tertiary Care Hospital in South India. 61
29911030 2018
394
An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report. 61
29517680 2018
395
Hair and nail diseases in the mature patient. 61
29566920 2018
396
Case Report of Connubial Frontal Fibrosing Alopecia. 61
29769781 2018
397
Graft versus Host Disease Presenting as Fibrosing Alopecia in a Pattern Distribution: A Model for Pathophysiological Understanding of Cicatricial Pattern Hair Loss. 61
29769782 2018
398
Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis. 61
29529997 2018
399
Variation in male sex hormone levels among the pattern subtypes of hair loss in patients with androgenetic alopecia. 61
28266054 2018
400
Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors. 61
29330930 2018
401
The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study. 61
29166130 2018
402
The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years. 61
29319278 2018
403
Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For. 61
29209995 2018
404
Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia. 61
29101437 2018
405
Androgenic alopecia in a postmenopausal Sicilian baroness. 61
29103134 2018
406
Prostaglandin D2-Mediated DP2 and AKT Signal Regulate the Activation of Androgen Receptors in Human Dermal Papilla Cells. 61
29439547 2018
407
Establishment and characterization of five immortalized human scalp dermal papilla cell lines. 61
29331373 2018
408
Germacrone and sesquiterpene-enriched extracts from Curcuma aeruginosa Roxb. increase skin penetration of minoxidil, a hair growth promoter. 61
29159692 2018
409
A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. 61
29407002 2018
410
Low-level laser therapy for the treatment of androgenic alopecia: a review. 61
29270707 2018
411
Microneedling: Where do we stand now? A systematic review of the literature. 61
28690124 2018
412
Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. 61
29483947 2018
413
Finasteride Topical Delivery Systems for Androgenetic Alopecia. 61
29366416 2018
414
Effectiveness of Platelet-Rich Plasma for Androgenetic Alopecia: A Review of the Literature. 61
29457005 2018
415
A Meta-analysis On Evidence Of Platelet-rich Plasma for Androgenetic Alopecia. 61
29440850 2018
416
Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach. 61
30104862 2018
417
Utility of Horizontal Sections of Scalp Biopsies in Differentiating between Androgenetic Alopecia and Alopecia Areata. 61
30092597 2018
418
Mediterranean diet: fresh herbs and fresh vegetables decrease the risk of Androgenetic Alopecia in males. 61
29181579 2018
419
Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia. 61
29443105 2018
420
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. 61
29178529 2018
421
Automatic Artificial Hair Implant: Safety and Efficacy in Androgenetic Alopecia. A Prospective Study with a Highly Biocompatible Fiber. 61
29483977 2018
422
Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia. 61
28562436 2018
423
Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study. 61
28562433 2018
424
Therapeutic Potential of Stem Cells in Follicle Regeneration. 61
30154860 2018
425
Medicinal Plants for the Treatment of Hair Loss and the Suggested Mechanisms. 61
30205796 2018
426
Sesquiterpene-Enriched Extract of Curcuma aeruginosa Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study. 61
29428960 2018
427
Does a male polycystic ovarian syndrome equivalent exist? 61
28711970 2018
428
Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication. 61
29457595 2018
429
Clinical Outcome and Safety Profile of Patients Underwent Hair Transplantation Surgery by Follicular Unit Extraction. 61
30058640 2018
430
Non-scarring Alopecias in Iranian Patients: A Histopathological Study With Hair Counts. 61
30636954 2018
431
The promotion of hair regrowth by topical application of a Perilla frutescens extract through increased cell viability and antagonism of testosterone and dihydrotestosterone. 61
28905175 2018
432
Alopecia and the metabolic syndrome. 61
29241753 2018
433
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study. 61
29139043 2018
434
Emotional Consequences of Finasteride: Fool's Gold. 61
26868914 2018
435
Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia. 61
28743526 2017
436
Hair loss at injection sites of mesotherapy for alopecia. 61
28160387 2017
437
Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients. 61
27988928 2017
438
[What is the value of low-energie lasers in the treatment of androgenetic alopecia ?] 61
29271134 2017
439
The role of oxidative stress in early-onset androgenetic alopecia. 61
27987270 2017
440
Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males. 61
31646132 2017
441
Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line. 61
30064598 2017
442
Effect of Ficus carica leaf extract on the gene expression of selected factors in HaCaT cells. 61
28432719 2017
443
Low plasma zinc levels in androgenetic alopecia. 61
28566562 2017
444
Regulatory pathways implicated in male androgenetic alopecia pathogenesis. 61
29192995 2017
445
Topical cetirizine 1% for treatment of androgenetic alopecia. 61
28796428 2017
446
Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors. 61
28528395 2017
447
Platelet-rich Plasma by Single Spin Process in Male Pattern Androgenetic Alopecia: Is it an Effective Treatment? 61
29204389 2017
448
Platelet-rich Plasma by Single-spin Process in Male Pattern Androgenetic Alopecia: Is it an Effective Treatment? 61
29204390 2017
449
Study of gene expression alteration in male androgenetic alopecia: evidence of predominant molecular signalling pathways. 61
28403520 2017
450
Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature. 61
28271918 2017
451
In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles. 61
28652158 2017
452
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review. 61
29447628 2017
453
New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach. 61
29141068 2017
454
GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. 61
29146897 2017
455
Efficacy of fractional lasers in treating alopecia: a literature review. 61
28812164 2017
456
Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation. 61
29254313 2017
457
Social selection favours offspring prone to the development of androgenetic alopecia. 61
29254307 2017
458
A Proposal of an Effective Platelet-rich Plasma Protocol for the Treatment of Androgenetic Alopecia. 61
29118521 2017
459
Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients. 61
28691187 2017
460
Dermatologic manifestations of endocrine disorders. 61
29184811 2017
461
Prostaglandin D2 Uses Components of ROS Signaling to Enhance Testosterone Production in Keratinocytes. 61
28941500 2017
462
Injections of platelet-rich plasma for androgenic alopecia: A systematic review. 61
28676455 2017
463
Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report. 61
29090364 2017
464
Exogen Hairs in Women with and without Hair Loss. 61
29177147 2017
465
Knockout of p16INK4a promotes aggregative growth of dermal papilla cells. 61
29267490 2017
466
Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis. 61
28296142 2017
467
Yellow dots in trichoscopy: relevance, clinical significance and peculiarities. 61
29166518 2017
468
Hair Loss: Common Causes and Treatment. 61
28925637 2017
469
Eccrine Duct Dilation as a Marker of Cicatricial Alopecia. 61
27673387 2017
470
Hair Transplantation in Migraine Headache Patients. 61
29062667 2017
471
Hair Regenerative Mechanisms of Red Ginseng Oil and Its Major Components in the Testosterone-Induced Delay of Anagen Entry in C57BL/6 Mice. 61
28885585 2017
472
Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America. 61
28370105 2017
473
Glycolipid and Hormonal Profiles in Young Men with Early-Onset Androgenetic Alopecia: A meta-analysis. 61
28798373 2017
474
Genomewide differential expression profiling of long non-coding RNAs in androgenetic alopecia in a Chinese male population. 61
28419572 2017
475
Genome-wide gene expression dataset used to identify potential therapeutic targets in androgenetic alopecia. 61
28589172 2017
476
The combination of overweight and smoking increases the severity of androgenetic alopecia. 61
28555720 2017
477
The Association between Exercise and Androgenetic Alopecia: A Survey-Based Study. 61
28761311 2017
478
Experimental and early investigational drugs for androgenetic alopecia. 61
28689433 2017
479
Preparation and in vivo evaluation of lecithin-based microparticles for topical delivery of minoxidil. 61
28770536 2017
480
Oxidative stress management in the hair follicle: Could targeting NRF2 counter age-related hair disorders and beyond? 61
28685843 2017
481
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia. 61
28932074 2017
482
Efficacy of topical caffeine in male androgenetic alopecia. 61
28677188 2017
483
A Pilot Study to Evaluate Effectiveness of Botulinum Toxin in Treatment of Androgenetic Alopecia in Males. 61
29403190 2017
484
Androgenetic alopecia: a review. 61
28349362 2017
485
A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia. 61
28263792 2017
486
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. 61
28396101 2017
487
Extensive Donor Site Keloids in Follicular Unit Extraction Hair Transplantation. 61
28932067 2017
488
Prevalence of fronto-vertex baldness and its association with family history of androgenetic alopecia in Korean men using basic and specific classification. 61
27599903 2017
489
Rejuvenation of the male scalp using 1,927 nm non-ablative fractional thulium fiber laser. 61
28117489 2017
490
Androgenic alopecia: an entity to consider in adolescence. 61
28754756 2017
491
Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. 61
28932059 2017
492
Higher plasma leptin is associated with higher risk of androgenetic alopecia in men. 61
28423238 2017
493
Adipocyte-myofibroblast transition as a possible pathophysiological step in androgenetic alopecia. 61
28482134 2017
494
Novel Approach to Treating Androgenetic Alopecia in Females With Photobiomodulation (Low-Level Laser Therapy). 61
28328705 2017
495
Infundibular protein and RNA microarray analyses from affected and clinically non-affected scalp in male androgenetic alopecia patients. 61
28266729 2017
496
Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both? 61
28621499 2017
497
Lipid profile in patients with androgenetic alopecia: a meta-analysis. 61
27717019 2017
498
Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles. 61
28324846 2017
499
Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain. 61
28161756 2017
500
Genetics and other factors in the aetiology of female pattern hair loss. 61
28453904 2017
501
Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases. 61
28214042 2017
502
A study of the efficacy of platelet-rich plasma in the treatment of androgenetic alopecia in males. 61
27679404 2017
503
Retrospective Assessment of Follicular Unit Density in Asian Men With Androgenetic Alopecia. 61
28362669 2017
504
The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study. 61
28221183 2017
505
Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss. 61
28249244 2017
506
Body to Scalp: Evolving Trends in Body Hair Transplantation. 61
28584752 2017
507
Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles. 61
31994100 2017
508
Comparison of the effects of 665 nm low level diode Laser Hat versus and a combination of 665 nm and 808nm low level diode Laser Scanner of hair growth in androgenic alopecia. 61
28513251 2017
509
A Spilt Head Study of Efficacy of Placebo versus Platelet-rich Plasma Injections in the Treatment of Androgenic Alopecia. 61
28852294 2017
510
Platelet-Rich Plasma in Androgenic Alopecia: Indications, Technique, and Potential Benefits. 61
27918883 2017
511
Enhanced restoration of in situ-damaged hairs by intradermal transplantation of trichogenous dermal cells. 61
25689375 2017
512
New Treatments for Hair Loss. 61
28061966 2017
513
Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. 61
28264599 2017
514
The evolution of artificial hair implantation. 61
28702978 2017
515
DERMAL ADIPOSE TISSUE IN HAIR FOLLICLE CYCLING: POSSIBLE APPLICATIONS IN ALOPECIA? 61
28574382 2017
516
Adult Onset Hair Casts: Nits Which Do Not Itch! 61
28839391 2017
517
Cutaneous Manifestations of Polycystic Ovary Syndrome: A Cross-Sectional Clinical Study. 61
28405549 2017
518
Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management. 61
27921251 2017
519
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia. 61
28024997 2017
520
Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. 61
27152474 2017
521
An Open-Label Evaluator Blinded Study of the Efficacy and Safety of a New Nutritional Supplement in Androgenetic Alopecia: A Pilot Study. 61
28367262 2017
522
A Critical Assessment of the Evidence for Low-Level Laser Therapy in the Treatment of Hair Loss. 61
27618394 2017
523
Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. 61
28216604 2017
524
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. 61
27549867 2017
525
An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia. 61
29055953 2017
526
A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia. 61
28761259 2017
527
An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia. 61
28594262 2017
528
Androgens modify Wnt agonists/antagonists expression balance in dermal papilla cells preventing hair follicle stem cell differentiation in androgenetic alopecia. 61
27769713 2017
529
Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss. 61
28725654 2017
530
Hair growth effect of traditional Chinese medicine BeauTop on androgenetic alopecia patients: A randomized double-blind placebo-controlled clinical trial. 61
28123489 2017
531
Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China. 61
28203058 2017
532
Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia. 61
28450835 2017
533
Comparative transcriptome profiling provides new insights into mechanisms of androgenetic alopecia progression. 61
27239811 2017
534
Low-level laser therapy as a treatment for androgenetic alopecia. 61
27114071 2017
535
A Case Report of Cushing's Disease Presenting as Hair Loss. 61
28413388 2017
536
[Typical androgenetic alopecia?] 61
27837206 2017
537
Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. 61
28225954 2017
538
Dutasteride in Androgenetic Alopecia: An Update. 61
28294070 2017
539
[Androgenetic alopecia in women]. 61
28722458 2017
540
Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia. 61
28689207 2017
541
A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia. 61
29911772 2017
542
[Mesotherapy in trichology]. 61
28722459 2017
543
[Psychological consequences of hair loss]. 61
28722460 2017
544
Conventional and novel stem cell based therapies for androgenic alopecia. 61
28979149 2017
545
Post-Finasteride Adverse Effects in Male Androgenic Alopecia: A Case Report of Vitiligo. 61
28222425 2017
546
Alopecia and platelet-derived therapies. 61
29270414 2017
547
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men. 61
29224108 2017
548
A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents. 61
28791288 2017
549
Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. 61
29167734 2017
550
The arrector pili muscle, the bridge between the follicular stem cell niche and the interfollicular epidermis. 61
27473595 2017
551
Platelet-rich plasma-an 'Elixir' for treatment of alopecia: personal experience on 117 patients with review of literature. 61
28815175 2017
552
Severity of Alopecia Predicts Coronary Changes and Arterial Stiffness in Untreated Hypertensive Men. 61
27365213 2017
553
Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium. 61
28761261 2017
554
Perception of Hair Transplant for Androgenetic Alopecia. 61
27560098 2016
555
Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. 61
27151518 2016
556
A new label-free screen for steroid 5α-reductase inhibitors using LC-MS. 61
27789379 2016
557
Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities. 61
28546817 2016
558
[Androgenetic alopecia: What's new in the last two years ?] 61
27814891 2016
559
A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia. 61
27631460 2016
560
Topical application of the Wnt/β-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia. 61
27121450 2016
561
Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature. 61
27499250 2016
562
Dermoscopy in General Dermatology: A Practical Overview. 61
27613297 2016
563
A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair. 61
27506633 2016
564
Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial. 61
27593381 2016
565
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens. 61
27750143 2016
566
Effects of flavonoid derivatives on human microvascular endothelial cells. 61
26936689 2016
567
Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? 61
27436801 2016
568
Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia. 61
27608205 2016
569
Multi-therapies in androgenetic alopecia: review and clinical experiences. 61
27424565 2016
570
Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans. 61
27028221 2016
571
Analysis of androgenetic alopecia in Amerindian people (Mapuche) from southern Chile. 61
27459731 2016
572
Asymmetry of the Receding Hairline in Men With Early Androgenetic Alopecia. 61
27421295 2016
573
Androgen excess: Investigations and management. 61
27387253 2016
574
Relevance of trichoscopy in the differential diagnosis of alopecia: A cross-sectional study from North India. 61
27297280 2016
575
Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain. 61
27046152 2016
576
Dermatologic care of the transgender patient. 61
28329583 2016
577
Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels. 61
27155830 2016
578
A New Subtype of Lichen Planopilaris Affecting Vellus Hairs and Clinically Mimicking Androgenetic Alopecia. 61
27661430 2016
579
Commentary on A New Subtype of Lichen Planopilaris Affecting Vellus Hairs and Clinically Mimicking Androgenetic Alopecia. 61
27661431 2016
580
Association of metabolic syndrome with female pattern hair loss in women: A case-control study. 61
27060965 2016
581
Generation of Pax1/PAX1-Specific Monoclonal Antibodies. 61
27705080 2016
582
Hair diseases: a big problem on a small surface. 61
27881935 2016
583
Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia. 61
26893187 2016
584
Study on the Efficacy of Platelet-rich Fibrin Matrix in Hair Follicular Unit Transplantation in Androgenetic Alopecia Patients. 61
27853485 2016
585
A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women. 61
27304785 2016
586
Germacrene Analogs are Anti-androgenic on Androgen-dependent Cells. 61
30807005 2016
587
Skin steroidogenesis in health and disease. 61
27761789 2016
588
Androgenetic Alopecia: An Update of Treatment Options. 61
27554257 2016
589
Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials. 61
27475241 2016
590
Cutaneuos findings in patients with predialysis chronic kidney disease. 61
27030004 2016
591
Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract. 61
26010505 2016
592
The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: A case-control study. 61
25781062 2016
593
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia. 61
27489426 2016
594
Differential Expression between Human Dermal Papilla Cells from Balding and Non-Balding Scalps Reveals New Candidate Genes for Androgenetic Alopecia. 61
27060448 2016
595
Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? 61
27656541 2016
596
An investigation of crosstalk between Wnt/β-catenin and transforming growth factor-β signaling in androgenetic alopecia. 61
27472703 2016
597
Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial. 61
26387973 2016
598
Illness perception in patients with androgenetic alopecia and alopecia areata in China. 61
27302539 2016
599
Female sexual dysfunction in androgenetic alopecia: Case-control study. 61
28255417 2016
600
Metabolic syndrome in androgenic alopecia. 61
27279298 2016
601
The Effect of Ovine Secreted Soluble Factors on Human Dermal Papilla Cell Aggregation. 61
27625561 2016
602
Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia? 61
26990657 2016
603
Reflectance confocal microscopy for scarring and non-scarring alopecia real-time assessment. 61
27225248 2016
604
A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia. 61
26608588 2016
605
Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk. 61
26585114 2016
606
Androgenetic alopecia. Modelling progression and regrowth. 61
27061176 2016
607
Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome. 61
26890011 2016
608
[Association of eight single nucleotide polymorphisms of chromosomes 20 and X with androgenetic alopecia among ethnic Han Chinese from Yunnan]. 61
27264827 2016
609
The topical penta-peptide Gly-Pro-Ile-Gly-Ser increases the proportion of thick hair in Japanese men with androgenetic alopecia. 61
27030543 2016
610
Epigallocatechin Gallate-Mediated Alteration of the MicroRNA Expression Profile in 5α-Dihydrotestosterone-Treated Human Dermal Papilla Cells. 61
27274631 2016
611
Digit-Length Ratios (2D:4D) as a Phenotypic Indicator of in Utero Androgen Exposure is Not Prognostic for Androgenic Alopecia: a Descriptive-Analytic Study of 1200 Iranian Men. 61
27942367 2016
612
Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease. 61
27386051 2016
613
Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship? 61
27489744 2016
614
Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays. 61
26990224 2016
615
Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. 61
27477178 2016
616
Topical adenosine increases the proportion of thick hair in Caucasian men with androgenetic alopecia. 61
26508659 2016
617
Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases. 61
27018067 2016
618
The Diagnosis and Treatment of Hair and Scalp Diseases. 61
27504707 2016
619
Atypical post-finasteride syndrome: A pharmacological riddle. 61
27298504 2016
620
[New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases]. 61
26383179 2016
621
Interventions for female pattern hair loss. 61
27225981 2016
622
Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males? 61
27192513 2016
623
The Relation of Androgenetic Alopecia Severity with Epicardial Fat Thickness. 61
27081268 2016
624
Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome. 61
26720591 2016
625
Psychosocial Impairment as a Possible Cause of Sexual Dysfunction among Young Men with Mild Androgenetic Alopecia: A Cross-sectional Crowdsourcing Web-based Study. 61
27149130 2016
626
Commentary on a Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. 61
26967461 2016
627
Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. 61
27035501 2016
628
Improvement of androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active compounds in the extract that stimulate proliferation of human hair keratinocytes. 61
26453439 2016
629
An observational Study of the Association between Androgenetic Alopecia and Size of the Prostate. 61
27601858 2016
630
Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia. 61
27050694 2016
631
Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia. 61
27050695 2016
632
Trichodynia: a review of the literature. 61
26696219 2016
633
Biofibre hair implant – impact on the quality of life. 61
27373130 2016
634
Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. 61
27601857 2016
635
Hunting the genes in male-pattern alopecia: how important are they, how close are we and what will they tell us? 61
26843402 2016
636
An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia. 61
26763726 2016
637
Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata. 61
26222765 2016
638
Guidelines on the use of finasteride in androgenetic alopecia. 61
26924401 2016
639
t-Flavanone Improves the Male Pattern of Hair Loss by Enhancing Hair-Anchoring Strength: A Randomized, Double-Blind, Placebo-Controlled Study. 61
26897375 2016
640
Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone. 61
26923074 2016
641
Oxidative stress in androgenetic alopecia. 61
27974920 2016
642
The association of urolithiasis and androgenetic alopecia. 61
26460579 2016
643
Update on the treatment of androgenetic alopecia. 61
26813453 2016
644
Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. 61
26636418 2016
645
Re: The association of urolithiasis and androgenetic alopecia. Resorlu M, Sancak EB, Uysal F, Arslan M, Diri A, Adam G, Akbas A, Sariyildirim A, Gulpinar MT, Resorlu B. Ren Fail. 2015 Oct 13:1-5. 61
26727394 2016
646
Whisker Hair (Acquired Progressive Kinking of the Hair): An Indication for Finasteride 1 mg? 61
27127372 2016
647
Scalp Hair Regrowth in Hormone-Treated Transgender Woman. 61
28861534 2016
648
A rare complication of follicular hair unit extraction: Kaposi's varicelliform eruption. 61
26937302 2016
649
Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice. 61
26571086 2016
650
Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assay. 61
26796631 2016
651
Platelet-Rich Plasma Growth Factor Concentrated Spray (Keratogrow®) as a Potential Treatment for Androgenic Alopecia. 61
28296870 2016
652
Efficacy of Activated 3X Platelet-Rich Plasma in the Treatment of Androgenic Alopecia. 61
28296871 2016
653
Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia. 61
26154267 2016
654
The Effect of One Session Low Level Laser Therapy of Extracted Follicular Units on the Outcome of Hair Transplantation. 61
27330694 2016
655
Classifications of Patterned Hair Loss: A Review. 61
27081243 2016
656
Human Mesenchymal Stem Cell-Derived Conditioned Media for Hair Regeneration Applications. 61
28296872 2016
657
Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth. 61
27162552 2016
658
Hair and Aging. 61
27871344 2016
659
Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain. 61
26646518 2016
660
Editorial - Mesenchymal Stem Cells in Androgenic Alopecia: Hair Loss Regeneration. 61
28296869 2016
661
Plasmacytoid dendritic cells in alopecia areata: missing link? 61
25545019 2016
662
Setting reference values in trichology. 61
26475211 2016
663
Appraisal of guidelines for androgenetic alopecia using the Appraisal of Guidelines for Research and Evaluation II instrument. 61
26507460 2015
664
Randomized Questionnaire Based Case-Control Research Study on Evaluation of Sexual Function in Indian Patients Taking Oral Finasteride for Androgenetic Alopecia. 61
26438381 2015
665
Lack of concordance and linkage disequilibrium among brothers for androgenetic alopecia and CAG/GGC haplotypes of the androgen receptor gene in Mexican families. 61
26178169 2015
666
Systematic review of the use of platelet-rich plasma in aesthetic dermatology. 61
26205133 2015
667
Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia. 61
25925959 2015
668
In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss. 61
26456343 2015
669
Bad Hair Day: Testosterone and Wnts. 61
26548488 2015
670
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial. 61
26400925 2015
671
Clinical and histological study of permanent alopecia after bone marrow transplantation. 61
26734861 2015
672
Evidence-based approach to cutaneous hyperandrogenism in women. 61
26138647 2015
673
Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. 61
26644787 2015
674
[Drug treatment of alopecia]. 61
26383761 2015
675
Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? 61
26903742 2015
676
Trichoscopic Findings of Hair Loss in Koreans. 61
26512168 2015
677
Identification of 5α-reductase isoenzymes in canine skin. 61
26175016 2015
678
Emerging Therapies for Androgenetic Alopecia. 61
26355625 2015
679
Atherogenic index of plasma in non-obese women with androgenetic alopecia. 61
26096895 2015
680
Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. 61
26031764 2015
681
Changes in the sebaceous gland in patients with male pattern hair loss (androgenic alopecia). 61
26147300 2015
682
Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? 61
26296373 2015
683
Prevalence and types of androgenetic alopecia in north Anatolian population: A community-based study. 61
26228320 2015
684
Prioritizing dermatoses: rationally selecting guideline topics. 61
25175822 2015
685
Correlation of Skin Changes with Hormonal Changes in Polycystic Ovarian Syndrome: A Cross-sectional Study Clinical Study. 61
26288423 2015
686
Involvement of Mechanical Stress in Androgenetic Alopecia. 61
26622151 2015
687
Conditions simulating androgenetic alopecia. 61
25571781 2015
688
Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. 61
25903108 2015
689
Study of the International Epidemiology of Androgenetic Alopecia in Young Caucasian Men Using Photographs From the Internet. 61
26288425 2015
690
Efficacy of platelet-rich plasma in treatment of androgenic alopecia. 61
26420936 2015
691
Analysis of the microRNA expression profile of normal human dermal papilla cells treated with 5α-dihydrotestosterone. 61
25778683 2015
692
Female Pattern Hair Loss: a clinical and pathophysiological review. 61
26375223 2015
693
Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study. 61
26133534 2015
694
Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis. 61
25204361 2015
695
Trichoscopic findings of androgenetic alopecia and their association with disease severity. 61
25810236 2015
696
Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia. 61
25871957 2015
697
Light-emitting Diodes: A Brief Review and Clinical Experience. 61
26155326 2015
698
Differential expression and functionality of ATP-binding cassette transporters in the human hair follicle. 61
25418064 2015
699
The Androgenic Alopecia Protective Effects of Forsythiaside-A and the Molecular Regulation in a Mouse Model. 61
25808759 2015
700
Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis. 61
25830296 2015
701
Effects of dihydrotestosterone on rat dermal papilla cells in vitro. 61
25838072 2015
702
Skin features in myotonic dystrophy type 1: an observational study. 61
25813338 2015
703
Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia. 61
25647436 2015
704
Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia. 61
26380504 2015
705
Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy. 61
26120151 2015
706
Oral Finasteride Presents With Sexual-Unrelated Withdrawal in Long-Term Treated Androgenic Alopecia in Men. 61
26380503 2015
707
Paracrine crosstalk between human hair follicle dermal papilla cells and microvascular endothelial cells. 61
25690790 2015
708
Characteristics of nonbalding scalp zones of androgenetic alopecia in East Asians. 61
25532463 2015
709
[Virilizing ovarian tumor: a rare cause of androgenetic alopecia]. 61
25813185 2015
710
Nail Involvement in Frontal Fibrosing Alopecia. 61
26180450 2015
711
Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles. 61
25085659 2015
712
Platelet-rich Plasma as a Potential Treatment for Noncicatricial Alopecias. 61
26180449 2015
713
Promising alternative clinical uses of prostaglandin F2α analogs: beyond the eyelashes. 61
25601618 2015
714
Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia. 61
25627907 2015
715
Lichen Planopilaris in the Androgenetic Alopecia Area: A Pitfall for Hair Transplantation. 61
27171849 2015
716
In vivo hair growth promotion effects of ultra-high molecular weight poly-γ-glutamic acid from Bacillus subtilis (Chungkookjang). 61
25502822 2015
717
Restorative effect of hair follicular dermal cells on injured human hair follicles in a mouse model. 61
25557326 2015
718
Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients. 61
23991834 2015
719
Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma. 61
24717976 2015
720
Quality evaluation of the Finasteride polymorphic forms I and II in capsules. 61
25527978 2015
721
A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men. 61
25765348 2015
722
Comment on "effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial". 61
25918542 2015
723
Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer. 61
24665929 2015
724
Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia. 61
25536913 2015
725
Evaluation of DNA variants associated with androgenetic alopecia and their potential to predict male pattern baldness. 61
26001114 2015
726
Clinical utility and validity of minoxidil response testing in androgenetic alopecia. 61
25112173 2015
727
Androgenetic alopecia is associated with increased arterial stiffness in asymptomatic young adults. 61
24628808 2015
728
Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. 61
25842469 2015
729
Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. 61
26339482 2015
730
[Female androgenetic alopecia, a survey of causes and therapeutic options]. 61
25994911 2015
731
Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome? 61
26617635 2015
732
Insulin resistance and skin diseases. 61
25977937 2015
733
Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients. 61
24628922 2015
734
Hair Follicle Plasticity with Complemented Immune-modulation Following Follicular Unit Extraction. 61
25878444 2015
735
Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride. 61
25657911 2015
736
Epidemiology and burden of alopecia areata: a systematic review. 61
26244028 2015
737
Hair restoration surgery: challenges and solutions. 61
26203266 2015
738
Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. 61
25657395 2015
739
Age-related hair changes in men: mechanisms and management of alopecia and graying. 61
25466305 2015
740
Scalp dermoscopy or trichoscopy. 61
26370641 2015
741
Female pattern hair loss. 61
26370643 2015
742
Molecular genetics of alopecias. 61
26370647 2015
743
Treatments options for alopecia. 61
26331694 2015
744
Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? 61
25597602 2015
745
Endocrine abnormalities in ring chromosome 11: a case report and review of the literature. 61
26576288 2015
746
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report. 61
26043832 2015
747
Advances in hair transplantation: longitudinal partial follicular unit transplantation. 61
26370653 2015
748
Minoxidil topical solution: an unsafe product for children. 61
25426682 2015
749
Safety and Efficacy of Rice Bran Supercritical CO2 Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial. 61
26632177 2015
750
5α-Reductase inhibitors in androgenetic alopecia. 61
25268732 2014
751
[Your patient complains about hair loss. Contribution of a skin biopsy in noncicatricial alopecias]. 61
25796787 2014
752
Emerging treatments in alopecia. 61
25330928 2014
753
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. 61
24855036 2014
754
Contribution of hair density and hair diameter to the appearance and progression of androgenetic alopecia in Japanese men. 61
24981717 2014
755
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment. 61
25437978 2014
756
Hair diameter vs. hair density in male androgenetic alopecia. 61
25409994 2014
757
Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. 61
24898559 2014
758
The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. 61
25382509 2014
759
A review of medical and surgical treatment options for androgenetic alopecia. 61
25188680 2014
760
Polycystic ovary syndrome: update on diagnosis and treatment. 61
24859638 2014
761
Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. 61
25722600 2014
762
A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. 61
25074865 2014
763
Complications of hair restoration surgery: a retrospective analysis. 61
25368473 2014
764
Unusual forms of alopecia areata in a Trichology Unit. 61
24033384 2014
765
Low-level laser therapy for androgenic alopecia. 61
25368481 2014
766
The growth of human scalp hair in females using visible red light laser and LED sources. 61
25124964 2014
767
Commentary on 'Platelet-rich plasma for androgenetic alopecia: a pilot study'. 61
25158780 2014
768
[Association between androgenetic alopecia and metabolic syndrome: a meta-analysis]. 61
25372648 2014
769
Platelet-rich plasma for androgenetic alopecia: a pilot study. 61
25111436 2014
770
Mycophenolate antagonizes IFN-γ-induced catagen-like changes via β-catenin activation in human dermal papilla cells and hair follicles. 61
25247578 2014
771
Impact of phototrichogram education on satisfaction of patients with androgenetic alopecia in clinical practice. 61
24986264 2014
772
Scalp dermatoscopic findings in androgenetic alopecia and their relations with disease severity. 61
25143677 2014
773
Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. 61
25254005 2014
774
Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. 61
24828032 2014
775
Effects of hyperandrogenism and high body mass index on acne severity in women. 61
25129194 2014
776
Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. 61
24681837 2014
777
A newly discovered linkage between proteoglycans and hair biology: decorin acts as an anagen inducer. 61
24942290 2014
778
Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat. 61
24942358 2014
779
Evidence for supplemental treatments in androgenetic alopecia. 61
25007363 2014
780
Androgenetic alopecia: an evidence-based treatment update. 61
24848508 2014
781
Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study. 61
25165643 2014
782
Hair morphology in androgenetic alopecia: sonographic and electron microscopic studies. 61
24958413 2014
783
Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. 61
24773771 2014
784
BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopecia. 61
24746780 2014
785
North American Virginian Witch Hazel (Hamamelis virginiana): Based Scalp Care and Protection for Sensitive Scalp, Red Scalp, and Scalp Burn-Out. 61
25210333 2014
786
Trichostasis spinulosa of the scalp mimicking Alopecia areata black dots. 61
25054768 2014
787
Potential targets in the discovery of new hair growth promoters for androgenic alopecia. 61
24873677 2014
788
Prevalence and associated factors of comorbid skin diseases in patients with schizophrenia: a clinical survey and national health database study. 61
24703505 2014
789
Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions. 61
24768424 2014
790
Destruction of the arrector pili muscle and fat infiltration in androgenic alopecia. 61
24579818 2014
791
Acne as a chronic systemic disease. 61
24767186 2014
792
Low-level laser/light therapy for androgenetic alopecia. 61
25134310 2014
793
Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss. 61
24352509 2014
794
Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications. 61
24850277 2014
795
Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years. 61
24979347 2014
796
Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. 61
24283387 2014
797
Reversible myopathy and ophthalmoparesis after low-dose finasteride administration for androgenic alopecia. 61
24533595 2014
798
Avicequinone C isolated from Avicennia marina exhibits 5α-reductase-type 1 inhibitory activity using an androgenic alopecia relevant cell-based assay system. 61
24858268 2014
799
Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia. 61
25191036 2014
800
The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss. 61